Analyst Reco. Alignment Healthcare, Inc.

Equities

ALHC

US01625V1044

Market Closed - Nasdaq Other stock markets 16:00:00 2024-04-26 EDT			5-day change	1st Jan Change
5.21 ^USD	+0.97%		+0.19%	-39.49%

04-23	Stifel Adjusts Alignment Healthcare's Price Target to $9 From $11, Maintains Buy Rating	MT
03-08	Transcript : Alignment Healthcare, Inc. - Special Call

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Stifel Adjusts Alignment Healthcare's Price Target to $9 From $11, Maintains Buy Rating	04-23	MT
Piper Sandler Downgrades Alignment Healthcare to Neutral From Overweight, Adjusts Price Target to $6 From $12	03-06	MT
UBS Adjusts Alignment Healthcare Price Target to $8.50 From $9, Maintains Neutral Rating	02-28	MT
Stifel Starts Coverage on Alignment Healthcare with Buy Rating, $11 Price Target	01-24	MT
Stephens Adjusts Price Target on Alignment Healthcare to $10.50 From $9, Keeps Equalweight Rating	01-09	MT
UBS Adjusts Alignment Healthcare Price Target to $9 From $6.50, Maintains Neutral Rating	12-21	MT
BofA Securities Downgrades Alignment Healthcare to Neutral From Buy	11-02	MT
Raymond James Upgrades Alignment Healthcare to Strong Buy From Outperform, Adjusts Price Target to $10 From $9	23-10-16	MT
Stephens Initiates Coverage on Alignment Healthcare with Equalweight Rating, $9 Price Target	23-10-12	MT
Morgan Stanley Adjusts Alignment Healthcare's Price Target to $12 From $19, Keeps Overweight Rating	23-08-30	MT
UBS Adjusts Alignment Healthcare Price Target to $6 From $8, Maintains Neutral Rating	23-07-13	MT
JPMorgan Adjusts Price Target on Alignment Healthcare to $10 From $12, Maintains Neutral Rating	23-07-07	MT
UBS Adjusts Alignment Healthcare Price Target to $8 From $10, Maintains Neutral Rating	23-05-05	MT
Raymond James Upgrades Alignment Healthcare to Outperform From Market Perform, Price Target is $9	23-05-01	MT
Goldman Sachs Adjusts Alignment Healthcare Price Target to $12 From $14, Maintains Buy Rating	23-04-18	MT
Goldman Sachs Adjusts Price Target on Alignment Healthcare to $14 From $21, Maintains Buy Rating	23-03-03	MT
Piper Sandler Adjusts Price Target on Alignment Healthcare to $12 From $19, Maintains Overweight Rating	23-03-03	MT
UBS Adjusts Alignment Healthcare's Price Target to $10 From $16, Maintains Neutral Rating	23-03-01	MT
JPMorgan Downgrades Alignment Healthcare to Neutral From Overweight, Adjusts Price Target to $12 From $22	23-02-23	MT
Raymond James Downgrades Alignment Healthcare to Market Perform From Outperform	22-11-21	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Alignment Healthcare, Inc.

Equities

ALHC

US01625V1044

Analyst Reco.

Filters